Tony Armstrong, president and CEO of Indiana University’s Research and Technology Corporation, and assistant vice president in the Office of the Vice President for Engagement.
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.